Galena Biopharma Inc


Stock Update (NASDAQ:GALE): Galena Biopharma Inc Announces Closing of Over-Allotment Option, Increasing Total Gross Proceeds to $43.7 Million

Galena Biopharma Inc (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of …

MLV Reiterates Buy on Galena Biopharma Inc Following Enrollment Expansion of NeuVax Combo Phase 2b

MLV’s healthcare analyst Vernon Bernardino came out with a few insights on Galena Biopharma Inc (NASDAQ:GALE), after the company announced expansion of targeted patient population for its ongoing …

MLV Pounds the Table on Galena Biopharma Inc

MLV analyst Vernon Bernardino was out pounding the table on Galena Biopharma Inc (NASDAQ:GALE) Monday, reiterating a Buy rating and a $5 price target, …

Cantor Remains Cautious on Galena Biopharma Inc Following 4Q Earnings

In a research report issued today, Cantor analyst Mara Goldstein maintained a Sell rating on Galena Biopharma Inc (NASDAQ:GALE) with a $2.00 price target, …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts